Thursday, 02 July, 2020

Chinese firm says coronavirus vaccine candidate shows promise in human test

WHO wants $18 billion in race for vaccine Potential coronavirus vaccine could be available from October
Gustavo Carr | 29 June, 2020, 23:30

If successful, this would be the first vaccine to be available in the global fight against the Covid-19 pandemic.

Organisations around the world are racing to find ways to treat and prevent the deadly pathogen, which first emerged in the central Chinese city of Wuhan and has since killed over half a million people worldwide.

Chinese companies and researchers have been allowed to test eight vaccine candidates in humans at home and overseas, making China a major front-runner in the race to develop a shot against the virus that has killed almost 500,000 people globally.

The company did not reveal to Reuters whether the inoculation of the vaccine candidate is mandatory or optional, citing commercial secrets.

China National Biotec Group (CNBG) said on Sunday that early human test results for a coronavirus vaccine candidate suggested it could be safe and effective, the second vaccine candidate from the firm to show encouraging results in a clinical trial.

U.S. indicts WikiLeaks' Julian Assange for hiring Anonymous & LulzSec
Assange is now in the high security Belmarsh prison in south London as he fights an extradition request by the United States. The DOJ had already accused Assange of plotting with Chelsea Manning to break into a Defense Department computer.

Now, China's Central Military Commission has approved the use of the drug by the military on June 25th for one year. The vaccine candidate was developed jointly by CanSino and a research institute at the Academy of Military Science (AMS). To stop it replicating, the virus is made inactive by removing certain genes.

The Phase 1 and 2 clinical trials of the CanSino's vaccine candidate showed it has the potential to prevent diseases caused by the coronavirus, which has killed half a million people globally, but its commercial success can not be guaranteed, the company said.

Brazil, the nation with the second-highest number of coronavirus cases and deaths, reached a deal with the United Kingdom to produce the Covid-19 vaccine that's been developed by Oxford University and AstraZeneca plc.

Another 131 candidate vaccines listed by the World Health Organization are in the pre-clinical phase.